NCT07025889

IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: RECRUITING

Phase: PHASE1, PHASE2

Sponsor: Ruijin Hospital

Condition: Gastric Cancer

Signal summary

Status signal: Low Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: None

Stopped reason

No stop reason available in the current public record.